03:47 PM EST - Nuvo Research Inc. : announced that Pennsaid, or diclofenac sodium topical solution, 1.5% w/w, is now available by prescription in U.S. pharmacies. Pennsaid is a non-steroidal anti-inflammatory drug or NSAID indicated for the treatment of the signs and symptoms of osteoarthritis of the knee(s). Nuvo Research Inc.
shares T.NRI are trading up $0.015 at $0.28.
